BioSpace News Archive

Business

Graybug Vision Reports Financial Results for the Three and Nine Months Ended September 30, 2022

Graybug Vision, Inc., a clinical-stage biopharmaceutical company focused historically on developing transformative medicines for ocular diseases, reported financial results for the three and nine months ended September 30, 2022.

November 10, 2022
·
6 min read
Business

Phio Announces New Appointments to Leadership Team, Reports on Third Quarter 2022 Financial Results and Provides Business Update

Phio Pharmaceuticals Corp. (Nasdaq: PHIO), today announced new appointments to the leadership team, reported its financial results for the quarter ended September 30, 2022 and provided a business update.

November 10, 2022
·
11 min read
Business

Predictive Oncology Reports Third Quarter Financial Results

Predictive Oncology Inc. (NASDAQ: POAI) today announced the financial results for its third quarter ended September 30, 2022, which continue to reflect revenue growth and increased gross profit margin as compared to prior year periods.

November 10, 2022
·
7 min read
Pharm Country

Vyant Bio Presents Key Takeaways from Platform and Poster Presentations at the 2022 CDKL5 Forum Hosted by the Loulou Foundation

Vyant Bio, Inc. (“Vyant Bio” or “Company”) (Nasdaq: VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders.

November 10, 2022
·
6 min read
Biotech Bay

Cutera, Inc. to Participate in a Fireside Chat at the Stephens Annual Investment Conference

Cutera, Inc. today announced that Dave Mowry, Chief Executive Officer, and Greg Barker, Vice President, Corporate FP&A, will participate in a fireside chat at the Stephens Annual Investment Conference at 4:00 pm CT on Wednesday, November 16, 2022, at the Grand Hyatt Hotel, Nashville, TN.

November 10, 2022
·
1 min read
Genetown

CRISPR Therapeutics Presents Data at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting

CRISPR Therapeutics today presented data for CTX130™ for the treatment of relapsed or refractory renal cell carcinoma (RCC) as an oral presentation delivered by City of Hope’s Sumanta Pal, M.D.

November 10, 2022
·
7 min read
Biotech Beach

Regen BioPharma Developing a Non-Exhaustible CAR-T Cell Therapeutic

Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP)has recently discussed the use of CAR-T therapies in cancer treatment.

November 10, 2022
·
3 min read
Sonrai Analytics novel platform empowers pharma / biotech to transform their own data into a multi-billion-dollar competitive edge

Global HealthTech venture firm Eckuity has announced today that it has invested in Sonrai Analytics, a commercial stage data management and bioinformatics company.

November 10, 2022
·
2 min read
QUE Oncology’s non-hormonal therapy reduces hot flushes and night sweats in women with breast cancer, published in The Lancet

QUE Oncology announces the results of its Phase II trial of Q-122, a novel non-hormonal oral therapy for the treatment of vasomotor symptoms in women taking endocrine therapy for breast cancer, have been published in The Lancet.

November 10, 2022
·
5 min read
Genetown

Scipher Medicine Announces Publication of Positive Results From AIMS Clinical Study

Scipher Medicine announced data validating the clinical utility of the company’s PrismRA test for guiding treatment selection for rheumatoid arthritis (RA) patients.

November 10, 2022
·
3 min read